SPEC is a student centric, multidisciplinary, research and holistic development oriented not for profit campus with a view to promote welfare. Within a short span of time, since 2007 till date, it has emerged as a campus known for teaching-learning-activities across the state of Gujarat.

The Nalanda Educational Society (NES) was established in the year 1991. The society was started with the objectives of imparting quality education to all aspiring students irrespective of caste, creed and religion, and to promote education in the backward area of Nalgonda district. The society was impelled to start Pharmacy College as there was no college in Nalgonda district, and due to ever increasing demand for the course in the district. Consequently, Nalanda College of Pharmacy (NCOP) was started in the year 1995 with B.Pharm course.

Established in 2000, HDFC Life is a leading long-term life insurance solutions provider in India, offering a range of individual and group insurance solutions that meet various customer needs such as Protection, Pension, Savings, Investment, Annuity and Health. As on March 31, 2020 the Company had 37 individual and 11 group products in its portfolio, along with 6 optional rider benefits, catering to a diverse range of customer needs.

Post : Graduate Trainee

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post : Assistant Manager Production

Teva is a global pharmaceutical leader and the worlds largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day.

Post : Quality Specialist III

Antiviral medicine molnupiravir which recently got approval from the CDSCO in India and is being manufactured by many pharma companies, has serious safety concerns, and thus has not been included in the national COVID-19 clinical protocol recommended by the health ministry, the Indian Council of Medical Research (ICMR) director general Balram Bhargava said.

Bhargava said the COVID-19 task force has debated twice whether to include the Molnupiravir in the COVID-19 treatment protocol but decided against it because of concerns.

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Vortioxetine Tablets 5 mg, 10 mg, 15 mg, and 20 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Trintellix Tablets 5 mg, 10 mg, 15 mg, and 20 mg, of Takeda Pharmaceuticals, USA, Inc. (Takeda). Vortioxetine Tablets are indicated for the treatment of major depressive disorder (MDD).

Sanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples. The companies have been working together since 2016 and in 2019, Sanofi in-licensed Exscientia’s novel bispecific small molecule candidate capable of targeting two distinct targets in inflammation and immunology.

HLL Lifecare Limited (HLL) is a Govt. of India Healthcare products manufacturing and services Company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare, HLL is a global leader in the area of contraceptives, hospital products and healthcare services. With 7 manufacturing units, 5 subsidiary companies and having presence in more than 100 countries, HLL is positioned as a total healthcare solution provider catering to the well-being ofthe society at large.

Banaras Hindu University ranks among the first few in the country in the field of academic and research output. This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools. The University is making its mark at the national and international levels in a number of frontier areas of Science, Social Science, Technology, Medicine and Agriculture etc.

The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October, 1933 by the University of Mumbai, through active support of industries and philanthropists. The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs.

Banaras Hindu University ranks among the first few in the country in the field of academic and research output. This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools. The University is making its mark at the national and international levels in a number of frontier areas of Science, Social Science, Technology, Medicine and Agriculture etc.

Applications are invited from the eligible candidates for the following posts.

Professor
Pharmaceutical Chemistry - 01
Pharmacognosy -01
Pharmacology - 01

Associate Professor
Pharmacy Practice - 01
Pharmacognosy - 01
Pharmaceutics - 01

Cadila Pharmaceuticals is an Indian multinational pharmaceutical group based in Ahmedabad, Gujarat, India. With more than 6 decades of experience, the companys integrated operations focus on manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products and pharmaceutical Machinery. Cadila Pharmaceuticals manufacturing facilities are approved by International bodies such as WHO-GMP, UK-MHRA, USFDA-API, TGA-Australia, and AIFA-Italy.

Zydus Cadila, a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain.

GIPS imparts skills to make graduates readily employable, by providing learning interface with Gland Pharma Ltd, a pioneer in parenteral preparations. Gland Institute of Pharmaceutical Sciences establshed in 2009. Approved by AICTE, PCI and Affiliated to JNTUH. Gland Institute of Pharmaceutical Sciences is committed to provide quality education in Pharmaceutical Sciences, and impart skills to make its graduates readily employable, by providing a learning interface with Pharma Industry.

More than 150 satisfied customers in 50 countries across the globe. Catering to client requirements in terms of offering wide range of customized generic and/or branded formulations. Wide basket of products across therapeutic areas and formulations. Lyophilized and Liquid Injectables ophthalmics, Externals, Liquid orals and Oral solid dosage forms. Strong back up of technically qualified R&D team for new formulation development as per individual client and market requirements. State of art WHO-GMP facilities to cater to your manufacturing requirements.

Janssen India, the pharmaceutical division of Johnson & Johnson India, is dedicated to addressing and solving some of the most important unmet medical needs of our time in India, in oncology, immunology, neuroscience and analgesia, dermatology, infectious diseases and metabolic diseases. Driven by a strong dedication to the health and well-being of patients, Janssen India brings innovative products, services and solutions to people throughout the world.

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.